Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.

To investigate the effects of arsenic trioxide (As(2)O(3)) on human T-lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 (MOLT-4/DNR) cells.
Cell growth was measured by an MTT assay. Cell viability was determined by a dye exclusion test. The level of P-gp expression was estimated using phycoerythrin-conjugated anti-P-gp monoclonal antibody 17F9. The function of P-gp was evaluated in terms of rhodamine 123 (Rh123) efflux. The percentage of cells undergoing apoptosis was determined by flow cytometry after staining with annexin V-FITC and propidium iodide.
As(2)O(3) inhibited the growth and survival of MOLT-4 and MOLT-4/DNR cells in a time- and dose-dependent manner. The 50% inhibitory concentrations of As(2)O(3) (IC(50)) against the growth of these cell lines were 5.1 micromol/l and 5.0 micromol/l, respectively, when the cells were treated with As(2)O(3) for 96 h. As(2)O(3) induced an apoptotic morphology in both MOLT-4 and MOLT-4/DNR cell lines. These effects of As(2)O(3) were time- and dose-dependent when the two cell lines were incubated in the presence of 1-8 micromol/l of As(2)O(3) for 3-144 h. As(2)O(3) treatment for 3 to 24 h at 5.0 micromol/l did not change the percentage of P-gp-expressing cells or the efflux ability of MOLT-4/DNR cells.
As(2)O(3) inhibited growth and induced apoptosis equally in MOLT-4 and MOLT-4/DNR cells, and this suppressive effect did not influence P-gp expression or function in MOLT-4/DNR cells.
AuthorsXiao-Mei Hu, Toshihiko Hirano, Kitaro Oka
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 51 Issue 2 Pg. 119-26 (Feb 2003) ISSN: 0344-5704 [Print] Germany
PMID12647012 (Publication Type: Journal Article)
Chemical References
  • Arsenicals
  • Oxides
  • P-Glycoprotein
  • arsenic trioxide
  • Daunorubicin
  • Apoptosis (drug effects)
  • Arsenicals (pharmacology)
  • Cell Division (drug effects)
  • Cell Survival (drug effects)
  • Daunorubicin (pharmacology)
  • Drug Resistance, Neoplasm
  • Humans
  • Oxides (pharmacology)
  • P-Glycoprotein (metabolism)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (pathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: